Qi Zhibing, Yao Xilan, Su Minggang, Huang Rui
Department of Nuclear Medicine, Jiujiang No.1 People's Hospital, Jiujiang, Jiangxi, China.
Hell J Nucl Med. 2023 May-Aug;26(2):155-156. doi: 10.1967/s002449912579. Epub 2023 Aug 4.
Gallium-68 (Ga)-prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) and fluorine-18-fluorodeoxyglucose(F-FDG) PET/CT were performed for staging in a 51-year-old man with renal cell carcinoma. Compared with F-FDG PET/CT, no obvious tracer uptake in right renal mass and less metastatic lesions were found on Ga-PSMA PET/CT. Postoperative pathology demonstrated the diagnosis of fumarate hydratase-deficient renal cell carcinoma (FHRCC).
对一名51岁的肾细胞癌男性患者进行了镓-68（Ga）-前列腺特异性膜抗原（PSMA）正电子发射断层扫描/计算机断层扫描（PET/CT）和氟-18-氟脱氧葡萄糖（F-FDG）PET/CT检查以进行分期。与F-FDG PET/CT相比，Ga-PSMA PET/CT显示右肾肿块无明显示踪剂摄取，转移灶较少。术后病理诊断为富马酸水合酶缺陷型肾细胞癌（FHRCC）。
